Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In the latest session, Evolent Health Inc (NYSE: EVH) closed at $3.94 down -1.75% from its previous closing price of $4.01. In other words, the price has decreased by -$1.75 from its previous closing price. On the day, 2.24 million shares were traded. EVH stock price reached its highest trading level at $4.145 during the session, while it also had its lowest trading level at $3.9245.
Ratios:
For a deeper understanding of Evolent Health Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.33 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 1.29 whereas as Long-Term Debt/Eq ratio is at 1.26.
On November 13, 2025, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $7.
On January 10, 2025, Needham started tracking the stock assigning a Buy rating and target price of $15.Needham initiated its Buy rating on January 10, 2025, with a $15 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 18 ’25 when Springstubb Brendan B bought 10,000 shares for $3.82 per share. The transaction valued at 38,199 led to the insider holds 58,821 shares of the business.
Holder Diane bought 2,735 shares of EVH for $25,518 on Mar 06 ’25. The Director now owns 70,584 shares after completing the transaction at $9.33 per share. On Mar 06 ’25, another insider, McCarthy Daniel Joseph, who serves as the PRESIDENT of the company, bought 11,040 shares for $9.01 each. As a result, the insider paid 99,470 and bolstered with 389,004 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EVH now has a Market Capitalization of 456926272 and an Enterprise Value of 1405372416. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.21 while its Price-to-Book (P/B) ratio in mrq is 0.52. Its current Enterprise Value per Revenue stands at 0.684 whereas that against EBITDA is 17.603.
Stock Price History:
The Beta on a monthly basis for EVH is 0.25, which has changed by -0.64408314 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, EVH has reached a high of $12.98, while it has fallen to a 52-week low of $3.49. The 50-Day Moving Average of the stock is -37.14%, while the 200-Day Moving Average is calculated to be -54.56%.
Shares Statistics:
For the past three months, EVH has traded an average of 3.63M shares per day and 3546930 over the past ten days. A total of 111.59M shares are outstanding, with a floating share count of 102.96M. Insiders hold about 7.74% of the company’s shares, while institutions hold 118.00% stake in the company. Shares short for EVH as of 1763078400 were 18762717 with a Short Ratio of 5.17, compared to 1760486400 on 17620752. Therefore, it implies a Short% of Shares Outstanding of 18762717 and a Short% of Float of 17.03.
Earnings Estimates
. The current assessment of Evolent Health Inc (EVH) involves the perspectives of 12.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.05, with high estimates of $0.17 and low estimates of -$0.04.
Analysts are recommending an EPS of between $0.13 and -$0.03 for the fiscal current year, implying an average EPS of $0.06. EPS for the following year is $0.3, with 9.0 analysts recommending between $0.78 and -$0.09.
Revenue Estimates
A total of 15 analysts believe the company’s revenue will be $469.68M this quarter.It ranges from a high estimate of $484.1M to a low estimate of $461.93M. As of. The current estimate, Evolent Health Inc’s year-ago sales were $646.54MFor the next quarter, 15 analysts are estimating revenue of $547.31M. There is a high estimate of $608.14M for the next quarter, whereas the lowest estimate is $510.91M.
A total of 15 analysts have provided revenue estimates for EVH’s current fiscal year. The highest revenue estimate was $1.89B, while the lowest revenue estimate was $1.87B, resulting in an average revenue estimate of $1.88B. In the same quarter a year ago, actual revenue was $2.55BBased on 11 analysts’ estimates, the company’s revenue will be $2.42B in the next fiscal year. The high estimate is $2.52B and the low estimate is $2.23B.
